Literature DB >> 33375334

Hybrid E/M Phenotype(s) and Stemness: A Mechanistic Connection Embedded in Network Topology.

Satwik Pasani1, Sarthak Sahoo1,2, Mohit Kumar Jolly1.   

Abstract

Metastasis remains an unsolved clinical challenge. Two crucial features of metastasizing cancer cells are (a) their ability to dynamically move along the epithelial-hybrid-mesenchymal spectrum and (b) their tumor initiation potential or stemness. With increasing functional characterization of hybrid epithelial/mesenchymal (E/M) phenotypes along the spectrum, recent in vitro and in vivo studies have suggested an increasing association of hybrid E/M phenotypes with stemness. However, the mechanistic underpinnings enabling this association remain unclear. Here, we develop a mechanism-based mathematical modeling framework that interrogates the emergent nonlinear dynamics of the coupled network modules regulating E/M plasticity (miR-200/ZEB) and stemness (LIN28/let-7). Simulating the dynamics of this coupled network across a large ensemble of parameter sets, we observe that hybrid E/M phenotype(s) are more likely to acquire stemness relative to "pure" epithelial or mesenchymal states. We also integrate multiple "phenotypic stability factors" (PSFs) that have been shown to stabilize hybrid E/M phenotypes both in silico and in vitro-such as OVOL1/2, GRHL2, and NRF2-with this network, and demonstrate that the enrichment of hybrid E/M phenotype(s) with stemness is largely conserved in the presence of these PSFs. Thus, our results offer mechanistic insights into recent experimental observations of hybrid E/M phenotype(s) that are essential for tumor initiation and highlight how this feature is embedded in the underlying topology of interconnected EMT (Epithelial-Mesenchymal Transition) and stemness networks.

Entities:  

Keywords:  epithelial–mesenchymal transition; hybrid epithelial/mesenchymal; phenotypic plasticity; phenotypic stability factors; stemness

Year:  2020        PMID: 33375334     DOI: 10.3390/jcm10010060

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  5 in total

Review 1.  Partial EMT in Squamous Cell Carcinoma: A Snapshot.

Authors:  Chengcheng Liao; Qian Wang; Jiaxing An; Qian Long; Hui Wang; Meiling Xiang; Mingli Xiang; Yujie Zhao; Yulin Liu; Jianguo Liu; Xiaoyan Guan
Journal:  Int J Biol Sci       Date:  2021-07-13       Impact factor: 6.580

2.  Nrf2 Modulates the Hybrid Epithelial/Mesenchymal Phenotype and Notch Signaling During Collective Cancer Migration.

Authors:  Samuel A Vilchez Mercedes; Federico Bocci; Mona Ahmed; Ian Eder; Ninghao Zhu; Herbert Levine; José N Onuchic; Mohit Kumar Jolly; Pak Kin Wong
Journal:  Front Mol Biosci       Date:  2022-04-08

3.  Mapping phenotypic heterogeneity in melanoma onto the epithelial-hybrid-mesenchymal axis.

Authors:  Maalavika Pillai; Gouri Rajaram; Pradipti Thakur; Nilay Agarwal; Srinath Muralidharan; Ankita Ray; Dev Barbhaya; Jason A Somarelli; Mohit Kumar Jolly
Journal:  Front Oncol       Date:  2022-08-08       Impact factor: 5.738

4.  Analysis of immune subtypes across the epithelial-mesenchymal plasticity spectrum.

Authors:  Priyanka Chakraborty; Emily L Chen; Isabelle McMullen; Andrew J Armstrong; Mohit Kumar Jolly; Jason A Somarelli
Journal:  Comput Struct Biotechnol J       Date:  2021-06-17       Impact factor: 7.271

5.  Transcriptomic-Based Quantification of the Epithelial-Hybrid-Mesenchymal Spectrum across Biological Contexts.

Authors:  Susmita Mandal; Tanishq Tejaswi; Rohini Janivara; Syamanthak Srikrishnan; Pradipti Thakur; Sarthak Sahoo; Priyanka Chakraborty; Sukhwinder Singh Sohal; Herbert Levine; Jason T George; Mohit Kumar Jolly
Journal:  Biomolecules       Date:  2021-12-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.